Quick Answer
NRX Pharmaceuticals, Inc. reported Shares Outstanding of 31.73 million shares for fiscal year 2025.
NRX Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 31.73M | +117.5% |
| 2024 | 14.59M | +73.9% |
| 2023 | 8.39M | -87.4% |
| 2022 | 66.44M | +13.0% |
| 2021 | 58.81M | +36.9% |
| 2020 | 42.97M | +1410.8% |
| 2019 | 2.84M | +4.4% |
| 2018 | 2.73M | +5.2% |
| 2017 | 2.59M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 27.68M | +143.4% | +42.2% |
| June 30, 2025 | 19.47M | +80.5% | +13.7% |
| March 31, 2025 | 17.12M | +78.3% | +17.3% |
| December 31, 2024 | 14.59M | +73.9% | +28.3% |
| September 30, 2024 | 11.37M | -86.4% | +5.4% |
| June 30, 2024 | 10.79M | -86.6% | +12.4% |
| March 31, 2024 | 9.60M | -86.3% | +14.4% |
| December 31, 2023 | 8.39M | -87.4% | -90.0% |
- NRX Pharmaceuticals, Inc. showed an increase of +117.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2017–2025 period, NRX Pharmaceuticals, Inc.’s shares outstanding has grown by 1124.8% (from 2.59 million shares to 31.73 million shares).
- The most recent figure is from NRX Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: